Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary

References

• Koos R. D. Ovarian angiogenesis. Comprehensive Endocrinology: The Ovary , P. C. K. Leung, E. Y. Adashi. Raven Press, New York 1993; 433–53
   Google Scholar
• Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 1995; 146: 1029–39
   PubMed Web of Science ®Google Scholar
• Neufeld G., Tessler S., Gitay-Goren H., Cohen T., Levi B. Z. Vascular endothelial growth factor and its receptors. Prog. Growth Factor Res. 1994; 5: 89–97
   PubMedGoogle Scholar
• Kamat B. R., Brown L. F., Manseau E. J., Senger D. R., Dvorak H. F. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 1995; 146: 157–65
   PubMed Web of Science ®Google Scholar
• Phillips H. S., Hains J., Leung D. W., Ferrara N. Vascular endothelial growth factor is expressed in rat corpora lutea. Endocrinology 1990; 127: 965–7
   PubMed Web of Science ®Google Scholar
• Ravindranath N., Little-Ihrig L., Phillips H. S., Ferrary N., Zeleznik A. J. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 1992; 131: 254–60
   PubMed Web of Science ®Google Scholar
• Gordon J. D., Mesiano S., Zaloudek C. J., Jaffe R. B. Vascular endothelial growth factor localization in human ovary and Fallopian tubes: possible role in reproductive function and ovarian cyst formation. J. Clin. Endocrinol. Metab. 1996; 81: 353–9
   PubMed Web of Science ®Google Scholar
• Yan Z., Weich H. A., Bernart W., Breckwoldt M., Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells. in vitro. J. Clin. Endocrinol. Metab. 1993; 77: 1723–5
   PubMed Web of Science ®Google Scholar
• Tsafriri A., Adashi E. Y. Local nonsteroidal regulators of ovarian function. The Physiology ojReproduction 2nd ed., E. Knobil, J. D. Neill. Raven Press, New York 1994; 817–60
   Google Scholar
• Gospodarowicz D., Cheng J., Lui G. M., Bohlen P. Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 1985; 117: 2283–391
   Web of Science ®Google Scholar
• Yamamoto S., Konishi I., Nanbu K., Komatsu T., Mandai M., Kuroda H., Matsushita K., Mori T. Immunohistochemical localization of basic fibroblast growth factor (bFGF) during folliculogenesis in the human ovary. Gynecol. Endocrinol 1997; 11: 223–30
   PubMed Web of Science ®Google Scholar
• Noyes R. W., Hertig A. T., Rock J. Dating the endometrial biopsy. Fertil. Steril 1950; 1: 3–10
   Web of Science ®Google Scholar
• Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum. Reprod. 1986; 1: 81–7
   PubMed Web of Science ®Google Scholar
• Harrison-Woolrych M. L., Sharkey A. M., Charnock-Jones D. S., Smith S. K. Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata. J. Clin. Endocrinol. Metab. 1995; 80: 1853–8
   PubMed Web of Science ®Google Scholar
• Celis J. E., Bravo R., Larsen P. M., Fey S. J. Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk. Res. 1984; 8: 143–57
   PubMed Web of Science ®Google Scholar
• Hall P. A., Levinson D. A., Woods A. L., Yu C. C. W., Kellock D. B., Watkins J. A., Barnes D. M., Gillett C. E., Camplejohn R., Waseem N. H., Lane D. P. Proliferating nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 1990; 162: 285–94
   PubMed Web of Science ®Google Scholar
• Parums D. V., Cordell J. L., Micklem K., Heryet A. R., Gatter K. C., Mason D. Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol. 1990; 43: 752–7
   PubMed Web of Science ®Google Scholar
• Horak E. R., Leek R., Klenk N., Lejeune S., Smith K., Stuart N., Greenall M., Stepniewska K., Harris A. L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120–4
   PubMed Web of Science ®Google Scholar
• Matsuzaki K., Yoshitake Y., Matuo Y., Sasaki H., Nishikawa K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. Natl Acad. Sci. USA 1989; 86: 9911–5
   PubMed Web of Science ®Google Scholar
• Nanbu K., Konishi I., Yamamoto S., Koshiyama M., Mandai M., Komatsu T., Li W., Tokushige M., Higuchi K., Mori T. Minimal deviation adenocarcinoma of endometrioid type may arise in the isthmus. Gynecol. Oncol. 1995; 58: 136–41
   PubMed Web of Science ®Google Scholar
• Garrido C., Saule S., Gospodarowicz D. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors 1993; 8: 109–17
   PubMed Web of Science ®Google Scholar
• Neulen J., Yan Z., Raczek S., Weindel K., Keck C., Weich H. A., Marme D., Breckwoldt M. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab. 1995; 80: 1967–71
   PubMed Web of Science ®Google Scholar
• Folkman J., Klagsbrun M., Sasse J., Wadzinsky M., Ingber D., Vlodavsky I. Aheparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane. Am. J. Pathol. 1988; 130: 393–400
   PubMed Web of Science ®Google Scholar
• Dissen G. A., Lara H. E., Fahrenbach W. H., Costa M. E., Ojeda S. R. Immature rat ovaries become revascularized rapidly after autotransplantation and show a gonadotropin-dependent increase in angiogenic factor gene expression. Endocrinology 1994; 134: 1146–54
   PubMed Web of Science ®Google Scholar
• McClure N., Healy D. L., Rogers P. A., Sullivan J., Beaton L., Haning R. V., Connolly D. T., Robertson D. M. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994; 344: 235–6
   PubMed Web of Science ®Google Scholar
• Robertson D., Selleck K., Suikkari A. M., Hurley V., Moonhan J., Healy D. Urinary vascular endothelial growth factor concentrations in women undergoing gonadotropin treatment. Hum. Reprod. 1995; 10: 2478–82
   PubMed Web of Science ®Google Scholar
• Krasnow J. S., Zeleznik A. J., Berga S. L., Yeo K. T., Guzick D. S. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril. 1996; 65: 552–5
   PubMed Web of Science ®Google Scholar